- £71.85bn
- £84.92bn
- £30.33bn
- 87
- 44
- 99
- 92
REG - GSK PLC - GSK RSV vaccine for older adults approved in Japan
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 21/09/2023
AnnouncementREG - GSK PLC - Apretude for PrEP receives EMA approval
AnnouncementREG - GSK PLC - FDA approves Ojjaara (momelotinib)
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Momelotinib filing accepted in Japan
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - GSK’s Nucala CRSwNP submission accepted in Japan
AnnouncementREG - GSK PLC Goldman Sachs Group. - Holding(s) in Company
AnnouncementREG - GSK PLC Goldman Sachs Group. - Holding(s) in Company
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Shingrix data demonstrate 100% efficacy in China
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
Announcement